Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients (CHeMoON)

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Not yet enrolling

Conditions: Gynecologic Cancers

Treatments: Behavioral: online survey

Study type: Observational

Funder types: Other

Identifiers

NCT07483905

Study ID 26945 (Other Identifier)

26945

Details and patient eligibility

About

This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.

Full description

Long-duration chemotherapy infusions are increasingly used in the treatment of gynecologic cancers. These treatments often require prolonged administration times that may extend over several hours and may affect patients' daily activities and quality of life when delivered during standard daytime hospital schedules. The implementation of a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions could represent an alternative organizational model aimed at improving patient convenience and optimizing hospital resource utilization. However, the acceptability of such a service from the patients' perspective has not been well explored.

This observational study will evaluate the interest and perceived acceptability of a nighttime Day Hospital service among patients with gynecologic cancers who may receive long-duration chemotherapy infusions. Data will be collected through an anonymous online survey administered to eligible patients. The questionnaire will explore patient preferences, potential advantages and disadvantages, logistical considerations, and willingness to receive chemotherapy during nighttime hours.

The results of this study may provide preliminary information on patient perspectives and help inform future organizational strategies for the delivery of prolonged chemotherapy infusions.

Enrollment: 200 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients
• aged 18 years or older
• Diagnosis of a gynecologic cancer
• Receiving care at the participating institution
• Ability to independently understand and complete complete the anonymous online survey

Exclusion criteria

• Inability to access or complete the online questionnaire or difficulty with reading and writing
• Cognitive impairment
• Patients currently hospitalized or in emergency settings.

Trial design

200 participants in 1 patient group

Patients with gynecologic cancers

Description:

Patients affected by gynecologic cancers receiving care at the participating institution who are invited to complete an anonymous online survey assessing their interest in a nighttime Day Hospital service for long-duration chemotherapy infusions.

Treatment:

Behavioral: online survey